Banner Title
의료진 소개
강병희 교수
방사선종양학과, 유방센터, 뇌정위방사선치료센터 관심의료진 등록전문 진료 분야
유방암, 뇌종양, 두경부암, 폐암, 소아암, 전이 암의 방사선치료
진료 일정
학력사항
- 서울대학교 의학전문대학원 석사
- 서울대학교 의과대학원 박사
교육 및 연구경력
- 2023-2024 | 이대서울병원 방사선종양학과 전임의
- 2022-2023 | 서울대병원 방사선종양학과 임상강사
- 2018-2022 | 서울대병원 방사선종양학과 전공의
- 2017-2018 | 서울대병원 인턴
수상경력
- 2022 | 대한방사선종양학회 전시상
- 2021 | 대한암학회(KCA) 학술대회 Poster Award
- 2021 | 대한방사선종양학회 정기학술대회 구연상
기타 학술 관련 경력
- 2022-2023 | 대한방사선종양학회 정회원
논문
- Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment. 2022-12.
- Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small-cell lung cancer. Frontiers in Oncology. 2022-08.
- Retropharyngeal lymph node-sparing radiotherapy in patients with oropharyngeal carcinoma. Radiation Oncology Journal. 2021-06.
- Nomogram for predicting the pathological tumor response from pre-treatment clinical characteristics in rectal cancer. Anticancer research. 2020-04.
- Early closure of a phase 1 clinical trial for SABR in early-stage glottic cancer. International Journal of Radiation Oncology* Biology* Physics. 2019-09.
- OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer. Oncotarget. 2015-08.
- Ctbp2 modulates NuRD-mediated deacetylation of H3K27 and facilitates PRC2-mediated H3K27me3 in active embryonic stem cell genes during exit from pluripotency. Stem cells. 2015-08.
- AMP-activated protein kinase phosphorylates CtBP1 and down-regulates its activity. Biochem Biophys Res Commun. Biochemical and Biophysical Research Communications. 2013-02.